コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y virus, equine infectious anemia virus, and feline immunodeficiency virus.
2 been obtained from animals infected with the feline immunodeficiency virus.
3 us, human immunodeficiency virus type 1, and feline immunodeficiency virus.
4 his model can also explain 3TC resistance in feline immunodeficiency virus and human hepatitis B viru
6 ly inhibit replication of human, simian, and feline immunodeficiency viruses and therefore has broad-
7 the dominant selective force acting on this feline immunodeficiency virus as it replicates in a new
9 d into the articular joint space a defective feline immunodeficiency virus capable of infecting divid
10 ne was prepared from a pathogenic isolate of feline immunodeficiency virus containing a mutation that
11 s, we evaluated the molecular evolution of a feline immunodeficiency virus derived from a wild cougar
12 ion, delivery of this shRNA by a recombinant feline immunodeficiency virus effectively silenced torsi
13 tant role that CXCR4 plays in infection with feline immunodeficiency virus, expression on PBMC in viv
14 ction with the prototypic Petaluma strain of feline immunodeficiency virus (FIV(PET)) using vaccines
15 GFAP-IL-1betaXAT mice were injected with the feline immunodeficiency virus (FIV) (Cre) vector in the
18 To determine its antiviral activity against feline immunodeficiency virus (FIV) and HIV, the activit
20 ThX and mock-ThX cats were inoculated with feline immunodeficiency virus (FIV) and monitored for th
23 semen from male domestic cats infected with feline immunodeficiency virus (FIV) can transmit virus t
29 6-residue multiepitopic synthetic peptide of feline immunodeficiency virus (FIV) comprising immunodom
30 tested the hypothesis that vectors based on feline immunodeficiency virus (FIV) could be used for co
32 combinant soluble CD134 (sCD134) facilitated feline immunodeficiency virus (FIV) entry into CXCR4-pos
34 (n = 19) had been chronically infected with feline immunodeficiency virus (FIV) for over 6 years, wh
36 an immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus (FIV) had different patter
38 Similar to human immunodeficiency virus, feline immunodeficiency virus (FIV) induces immunodefici
41 s during the acute stage (first 4 months) of feline immunodeficiency virus (FIV) infection in laborat
43 A monoclonal antibody, MAb vpg15, inhibits feline immunodeficiency virus (FIV) infection in tissue
47 vestigating the effect of CCR5 expression on feline immunodeficiency virus (FIV) infection must be in
48 cells (Tregs) activated during the course of feline immunodeficiency virus (FIV) infection suppress C
50 rly target cells and tissues in transmucosal feline immunodeficiency virus (FIV) infection, cats were
61 evelopment of gene delivery vectors based on feline immunodeficiency virus (FIV) is an attractive alt
63 ogenetic distance from primate lentiviruses, feline immunodeficiency virus (FIV) is becoming the lent
64 of equine infectious anemia virus (EIAV) and feline immunodeficiency virus (FIV) is inhibited by lept
68 ptional elements within the U3 domain of the feline immunodeficiency virus (FIV) long terminal repeat
74 candidates were tested for activity against feline immunodeficiency virus (FIV) on infected CrFK cel
76 were evaluated for their incorporation onto feline immunodeficiency virus (FIV) particles, transduct
79 A novel fluorogenic substrate for continuous feline immunodeficiency virus (FIV) protease (PR) assay
82 an immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus (FIV) proteases (PRs).
85 ilar to human immunodeficiency virus type 1, feline immunodeficiency virus (FIV) replicates in the th
86 ron (IFN-alpha) induced tetherin and blocked feline immunodeficiency virus (FIV) replication in lymph
87 regulatory properties and ability to support feline immunodeficiency virus (FIV) replication in vitro
90 ily conserved on both HIV type 1 (HIV-1) and feline immunodeficiency virus (FIV) reverse transcriptas
97 t syncytium formation mediated by strains of feline immunodeficiency virus (FIV) that have been selec
98 immunodeficiency virus (HIV) and strains of feline immunodeficiency virus (FIV) that have been selec
102 ssion in arthritic joints of mice, using the feline immunodeficiency virus (FIV) vector, which is cap
104 V), bovine immunodeficiency virus (BIV), and feline immunodeficiency virus (FIV) Vif appear specific
107 y RNA ligands for reverse transcriptase from feline immunodeficiency virus (FIV) were isolated from a
108 an immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus (FIV) were prepared to exa
109 binant Vif derived from the 34TF10 strain of feline immunodeficiency virus (FIV) were used to assess
110 we generated a defective mutant provirus of feline immunodeficiency virus (FIV) with an in-frame del
112 d from the pathogenic GL8 molecular clone of feline immunodeficiency virus (FIV), a range of viral va
113 xamined the brains of cats infected with the feline immunodeficiency virus (FIV), an animal model of
114 human immunodeficiency virus type 1 (HIV-1), feline immunodeficiency virus (FIV), and equine infectio
115 l leukemia virus type 1 (HTLV-1), HIV-1, and feline immunodeficiency virus (FIV), and have been postu
116 Human immunodeficiency virus type 1 (HIV-1), feline immunodeficiency virus (FIV), and Moloney murine
117 BIV), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), and Rous sarcoma vi
118 cells and cell lines did not restrict HIV-1, feline immunodeficiency virus (FIV), equine infectious a
120 of CD134 is the primary binding receptor for feline immunodeficiency virus (FIV), targeting the virus
121 (fCD134) is the primary binding receptor for feline immunodeficiency virus (FIV), targeting the virus
122 f human acquired immune deficiency syndrome, feline immunodeficiency virus (FIV), was used to model m
125 natural lung tropism; however, pseudotyping feline immunodeficiency virus (FIV)-based lentiviral vec
126 r efficiency and tissue or cell tropism of a feline immunodeficiency virus (FIV)-based lentiviral vec
127 pression following a single application of a feline immunodeficiency virus (FIV)-based lentivirus vec
128 epatoma cells following gene transfer with a feline immunodeficiency virus (FIV)-based lentivirus vec
129 arget these apical receptors, we pseudotyped feline immunodeficiency virus (FIV)-based vectors by usi
132 gical signals' alterations, we have used the feline immunodeficiency virus (FIV)-derived gp120 and ev
133 influence of the protease inhibitor TL-3 on feline immunodeficiency virus (FIV)-induced central nerv
134 We analyzed antibody responses in sera from feline immunodeficiency virus (FIV)-infected and uninfec
135 and immunodeficiency is a characteristic of feline immunodeficiency virus (FIV)-infected cats, it is
136 s were mucosally challenged with 10(2)-10(6) feline immunodeficiency virus (FIV)-infected T cells.
148 immunity to infection can be induced against feline immunodeficiency virus (FIV); however, protection
149 ase (IN) mutants for a non-human lentivirus (feline immunodeficiency virus [FIV]) and analyzed both t
151 onprimate lentiviral genomic RNAs (HIV-1 and feline immunodeficiency virus [FIV]) vis-a-vis their Gag
152 , we demonstrate that a fast-evolving virus (feline immunodeficiency virus, FIV) can reveal details o
153 transmission pathways for three subtypes of feline immunodeficiency virus (FIVPle ) in African lions
155 tranasal insulin treatment of experimentally feline immunodeficiency virus-infected animals resulted
158 s of MLV integrase and truncated variants of feline immunodeficiency virus integrase, suggesting that
160 ian immunodeficiency virus, puma lentivirus, feline immunodeficiency virus, Jembrana disease virus, v
161 The earliest experiments were in the cat/feline immunodeficiency virus model, followed a decade l
164 d with feline lentiviruses (puma lentivirus, feline immunodeficiency virus Pco [FIV-Pco], referred to
165 structures of complexes of a D30N mutant of feline immunodeficiency virus protease (FIV PR) complexe
167 es in success when targeting HIV-1 protease, feline immunodeficiency virus protease, and HIV-1 integr
168 S3' subsite binding specificities of HIV and feline immunodeficiency virus proteases (FIV) proteases
169 l cross-species transmission of a subtype of feline immunodeficiency virus, puma lentivirus A (PLVA),
172 of cells productively infected with HIV-1 or feline immunodeficiency virus revealed dramatic patterns
173 nus of tRNA(Lys,3) and the U5-IR loop of the feline immunodeficiency virus RNA genome suggests a nove
175 of HIV, infection of neonatal cats with the feline immunodeficiency virus, showed development of per
176 enetic diversity, and molecular evolution of feline immunodeficiency virus specific to cougars (FIVpc
177 used to compare the nucleotide sequences of feline immunodeficiency virus strains isolated from Texa
178 eported previously for functional binding of feline immunodeficiency virus SU to its coreceptor CD134
179 zed a highly pathogenic molecular isolate of feline immunodeficiency virus subtype C (FIV-C) CABCpady
180 of cellular receptors for human, simian, and feline immunodeficiency viruses that are tropic for lymp
183 , we report that human DC-SIGN also captures feline immunodeficiency virus via high-affinity (1 nM),
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。